Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014, its NoveHow Will The Data Protection Ruling On Ketamine Impact Psychedelic Novel Drug Development Moving Forward?Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic AnalogsSilo Pharma Advances Psychedelic Patent PortfolioTryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of FloridaMajor Psychedelic Clinical Trial Data Is Right Around The CornerPsychedelic Drug Development Companies Are Leveraging Bolt On MedTech Acquisitions To Create A More Robust Patient Care 7 Psychedelic Clinical Trials Underway That Investors Should Keep On Their RadarNuminus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into PSilo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide PatentTryp Therapeutics Announces Q3 2021 Financial ResultsKetamine One’s IRP Clinic Using Innovative NeuroCatch Platform to Measure Brain Function in Injured VeteransWake Network, Inc. and the Lieber Institute for Brain Development Announce Research CollaborationTryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of MichiganNuminus Wellness Reaches Major Milestone With MAPS Sponsored MDMA StudyNuminus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSDPsyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative Care Clinical TrialTryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary FormulationsPsyched Wellness Commences Next Pre-Clinical Study on AME-1Atai Life Sciences Is Setting The Standard For Psychedelic Drug Development

Technical420 Site Search

Returned 8 result(s).

Wake Network, Inc. and the Lieber Institute for Brain Development Announce Research Collaboration

Wake Network, Inc., a global leader in psilocybin mushroom research, production and the developer of genomics-based integration therapies, is pleased to announce a collaboration with the Lieber Institute for Brain Development (the " Lieber Institute "), a non-profit research Institution and an international leader in translating genetics into brain function,…

Psychedelic Clinics Are A Major Vertical That Investors Need To Be Watching

The clinic opportunity is an exciting vertical of the psychedelic industry and is a market that our readers need to be aware of. Last year, the psychedelic clinic market recorded significant advancements, and this is a trend that is expected to continue. We believe the negative mental health effects that…

3 Psychedelic Sector Leaders That Investors Need To Be Aware Of

The last few years have been significant for the psychedelic therapy industry and we believe the sector is in not even in the first inning of a major growth cycle. From a regulatory standpoint, the psychedelic therapy industry has reported significant advancements, and this is a trend that we expect…

Wake Network Is Laser Focused On Advancing Fungi-Based Medicine Through Cutting Edge Technology and Clinical Research

A few months ago, we highlighted Wake Network as a psychedelic therapy company that we consider to be a leading play on an emerging industry and want to provide an update on the opportunity. Wake Network is laser focused on advancing fungi and plant-based medicine by leveraging clinical research, wellness…

Is Psilocybin The Next Cannabis? These Two Bellwethers Make Us Think So

The psychedelic therapy market is an emerging industry that is not even in the first inning of a major growth cycle and there are several companies already working to bring breakthrough therapies for a range of mental health conditions to market. 2020 has been a banner year for the psychedelic…

Psychedelic Assisted Therapy Is Becoming A Very Real Alternative Method To Treat Mental Illness

Although the functional mushroom market has been getting a lot of attention, we are most excited about the progress that has been made on the biotech side of the psychedelic industry. There are a few companies in advanced stages of U.S. Food and Drug Administration (FDA) clinical trials and the…

The Multi-Billion Dollar Functional Mushroom Market Is Up For Grabs

One of the most exciting trends of 2020 has been the emergence of the functional mushroom market. This vertical has been generating substantial traction over the last decade and this is a trend that is only getting more significant. According to a report by Research and Markets, the global edible…

Wake Network Is Creating A Multi-Faceted Platform To Bring Psychedelic Therapies To Market

During the last month, we have seen a substantial increase in the amount of interest in the psychedelic market and this is an opportunity that we are closely following. We have been focused on identifying potential leaders in the psychedelic market and want to highlight a business that caught our…

Search Again

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link